A neuropsychosocial signature predicts longitudinal symptom changes in women with irritable bowel syndrome
- PMID: 34819635
- PMCID: PMC9095468
- DOI: 10.1038/s41380-021-01375-9
A neuropsychosocial signature predicts longitudinal symptom changes in women with irritable bowel syndrome
Abstract
Irritable bowel syndrome (IBS) is a common disorder of brain-gut interactions characterized by chronic abdominal pain, altered bowel movements, often accompanied by somatic and psychiatric comorbidities. We aimed to test the hypothesis that a baseline phenotype composed of multi-modal neuroimaging and clinical features predicts clinical improvement on the IBS Symptom Severity Scale (IBS-SSS) at 3 and 12 months without any targeted intervention. Female participants (N = 60) were identified as "improvers" (50-point decrease on IBS-SSS from baseline) or "non-improvers." Data integration analysis using latent components (DIABLO) was applied to a training and test dataset to determine whether a limited number of sets of multiple correlated baseline'omics data types, including brain morphometry, anatomical connectivity, resting-state functional connectivity, and clinical features could accurately predict improver status. The derived predictive models predicted improvement status at 3-months and 12-months with 91% and 83% accuracy, respectively. Across both time points, non-improvers were classified as having greater correlated morphometry, anatomical connectivity and resting-state functional connectivity characteristics within salience and sensorimotor networks associated with greater pain unpleasantness, but lower default mode network integrity and connectivity. This suggests that non-improvers have a greater engagement of attentional systems to perseverate on painful visceral stimuli, predicting IBS exacerbation. The ability of baseline multimodal brain-clinical signatures to predict symptom trajectories may have implications in guiding integrative treatment in the age of precision medicine, such as treatments targeted at changing attentional systems such as mindfulness or cognitive behavioral therapy.
© 2021. The Author(s).
Conflict of interest statement
Emeran A. Mayer, MD is a scientific advisory board member of Danone, Axial Biotherapeutics, Viome, Amare, Mahana Therapeutics, Pendulum, Bloom Biosciences and APC Microbiome Ireland. No other authors have no conflicts of interest to disclose.
Figures





Similar articles
-
A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.Neuropharmacology. 2023 Mar 1;225:109381. doi: 10.1016/j.neuropharm.2022.109381. Epub 2022 Dec 17. Neuropharmacology. 2023. PMID: 36539012 Free PMC article. Review.
-
Brain functional connectivity is associated with visceral sensitivity in women with Irritable Bowel Syndrome.Neuroimage Clin. 2017 Jun 2;15:449-457. doi: 10.1016/j.nicl.2017.06.001. eCollection 2017. Neuroimage Clin. 2017. PMID: 28649489 Free PMC article.
-
Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.Microbiome. 2021 Nov 30;9(1):236. doi: 10.1186/s40168-021-01188-6. Microbiome. 2021. PMID: 34847963 Free PMC article. Clinical Trial.
-
Networks Are Associated With Acupuncture Treatment in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Resting-State Imaging Study.Front Hum Neurosci. 2021 Oct 14;15:736512. doi: 10.3389/fnhum.2021.736512. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34720908 Free PMC article.
-
Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.Brain Behav Immun. 2011 Mar;25(3):386-94. doi: 10.1016/j.bbi.2010.11.010. Epub 2010 Nov 20. Brain Behav Immun. 2011. PMID: 21094682 Review.
Cited by
-
A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.Neuropharmacology. 2023 Mar 1;225:109381. doi: 10.1016/j.neuropharm.2022.109381. Epub 2022 Dec 17. Neuropharmacology. 2023. PMID: 36539012 Free PMC article. Review.
-
Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.J Clin Gastroenterol. 2025 May-Jun 01;59(5):385-392. doi: 10.1097/MCG.0000000000002149. Epub 2025 Feb 17. J Clin Gastroenterol. 2025. PMID: 39998940
-
Functional changes of default mode network and structural alterations of gray matter in patients with irritable bowel syndrome: a meta-analysis of whole-brain studies.Front Neurosci. 2023 Oct 24;17:1236069. doi: 10.3389/fnins.2023.1236069. eCollection 2023. Front Neurosci. 2023. PMID: 37942144 Free PMC article.
-
Positive psychological well-being and clinical characteristics in IBS: A systematic review.Gen Hosp Psychiatry. 2023 Mar-Apr;81:1-14. doi: 10.1016/j.genhosppsych.2023.01.004. Epub 2023 Jan 11. Gen Hosp Psychiatry. 2023. PMID: 36681019 Free PMC article.
-
Aberrant functional connectivity patterns in the pregenual anterior cingulate cortex and anterior midcingulate cortex of patients with irritable bowel syndrome accompanied by depressive symptoms.Brain Imaging Behav. 2025 Apr;19(2):279-290. doi: 10.1007/s11682-024-00964-w. Epub 2025 Jan 7. Brain Imaging Behav. 2025. PMID: 39775692
References
-
- Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949–58. - PubMed